Sort
15,842 grants matching “pancreatic cancer”
Role of ICAM1 in development and progression of pancreatic cancer
$357,994Peter Storz · Mayo Clinic Jacksonville · R01 · FY2019 · CA
Targeting PYK2 for the treatment of PDAC
$357,994Jing Hu · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
PKD1 signaling in the initiation of pancreatic cancer
$357,994Peter Storz · Mayo Clinic Jacksonville · R01 · FY2017 · CA
Role of ICAM1 in development and progression of pancreatic cancer
$357,994Peter Storz · Mayo Clinic Jacksonville · R01 · FY2020 · CA
The role of DCLK1 in the initiation of pancreatic ductal adenocarcinoma
$357,918Courtney Wayne Houchen · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2015 · CA
Microbial- based targeting of major extracellular matrix components for improved therapy of pancreatic cancer
$357,896Edwin Manuel · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
(PQD6) Muscle stem cells and cancer cachexia
$357,894Denis C Guttridge · Ohio State University · R01 · FY2014 · CA
Role of the SWI/SNF complex in tumor suppression
$357,826Charles W Roberts · St. Jude Children'S Research Hospital · R01 · FY2017 · CA
Tumor Antigens for Individual Signatures and Therapy
$357,758Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2012 · CA
The Role of Zinc Finger Cofactors in Pancreatic Cell Growth
$357,750Raul A Urrutia · Mayo Clinic Rochester · R01 · FY2014 · DK
The Role of Zinc Finger Cofactors in Pancreatic Cell Growth
$357,750Raul A Urrutia · Mayo Clinic Rochester · R01 · FY2016 · DK
The Role of Zinc Finger Cofactors in Pancreatic Cell Growth
$357,750Raul A Urrutia · Mayo Clinic Rochester · R01 · FY2015 · DK
Evaluation of Cancer Vaccines Based on MUC1processed by dendritic cells
$357,749Olivera J Finn · University Of Pittsburgh At Pittsburgh · P01 · FY2007 · CA
U01-Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers
$357,680Christopher E Forsmark · University Of Florida · U01 · FY2015 · DK
Project 1:Improving Pancreatic Risk Assessment
$357,641Alison P Klein · Johns Hopkins University · P50 · FY2018 · CA
Deregulation of COMPASS complex and enhancer chromatin in pancreatic cancer
$357,559Alexandros Tzatsos · George Washington University · R01 · FY2022 · CA
Reprogramming the Tumor Microenvironment in Pancreas Cancer to Enhance Immunotherapy
$357,535Nipun B. Merchant · University Of Miami School Of Medicine · R01 · FY2018 · CA
EPIGENETIC LICENSING OF PANCREATIC CANCER METASTASIS
$357,500Fundacio Institut De Recerca Biomedica (Irb Barcelona) · · FY2022 · Department of the Army
Tumor-intrinsic and paracrine roles of endoglin in pancreatic cancer
$357,480Nam Y Lee · University Of Arizona · R01 · FY2024 · CA
Identification of genes related to spcific properties of mammalian cells
$357,416Joseph Shiloach · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
Quantitative Mass Spectrometry
$357,373Kenneth Tomer · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES
TGF-beta Signaling in Pancreatic Cancer
$357,363Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2009 · CA
Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy
$357,337David G Denardo · Washington University · P50 · FY2016 · CA
Understanding and targeting mutant splicing factors in pancreatic cancer
$357,313Luisa Escobar Hoyos · Yale University · R01 · FY2024 · CA
Molecular Basis of BRCA2-mediated DNA Repair and Cancer Avoidance
$357,310Patrick Sung · Yale University · R01 · FY2011 · ES